FindMyRecallSubscribe
Class I: serious health riskTerminated

X-Gen Pharmaceuticals Ibuprofen Lysine Injection Recall

Ibuprofen Lysine Injection, 20 mg/2 mL (10 mg/mL), 2 mL Single-Dose Vial (NDC 39822-103…

X-Gen Pharmaceuticals Inc. · Horseheads, NY

Risk level
Class I
Reported by FDA
Apr 12, 2017
Recall ID
D-0637-2017
Check your lot numberHow we source this data

Summary

X-Gen Pharmaceuticals recalled Ibuprofen Lysine Injection starting Feb 8, 2017. The FDA classified it as Class I (serious health risk) and published enforcement report D-0637-2017 on Apr 12, 2017. Reason: Presence of Particulate Matter. Status: Terminated.

Why it was recalled

Presence of Particulate Matter

Product description

Ibuprofen Lysine Injection, 20 mg/2 mL (10 mg/mL), 2 mL Single-Dose Vial (NDC 39822-1030-1), packaged in 3 x 2 mL Single-Dose Vials per carton (NDC 39822-1030-2); Rx only, Distributed by: X-Gen Pharmaceuticals, Inc., Big Flats, NY 14814; Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645.

Lot numbers, UPCs & expiration codes

PLND1613, Exp 02/18

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0637-2017
Classification
Class I
Status
Terminated
Recall initiated
Feb 8, 2017
FDA report date
Apr 12, 2017
Quantity
2593 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
X-Gen Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0637-2017, exactly as published.

Show all FDA fields
City
Horseheads
State
NY
Status
Terminated
Country
United States
Event ID
76410
Address
300 Daniel Zenker Dr
Code information
PLND1613, Exp 02/18
Postal code
14845-1014
Report date
Apr 12, 2017
Product type
Drugs
Recall number
D-0637-2017
Classification
Class I
Recalling firm
X-Gen Pharmaceuticals Inc.
Product quantity
2593 cartons
Termination date
Jun 10, 2020
Reason for recall
Presence of Particulate Matter
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ibuprofen Lysine Injection, 20 mg/2 mL (10 mg/mL), 2 mL Single-Dose Vial (NDC 39822-1030-1), packaged in 3 x 2 mL Single-Dose Vials per carton (NDC 39822-1030-2); Rx only, Distributed by: X-Gen Pharmaceuticals, Inc., Big Flats, NY 14814; Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Feb 8, 2017
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Apr 5, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0637-2017, published Apr 12, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls